Hearing lossSensorion achieves milestones in Phase II trialLatest NewsFrench Sensorion SA has reported new efficacy endpoints data from SENS-401 in a Phase II study for the preservation of residual hearing loss. Read more 15 July 2024 https://european-biotechnology.com/wp-content/uploads/2024/07/Ohr.jpg 853 1280 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-07-15 11:17:082024-07-16 18:23:12Sensorion achieves milestones in Phase II trial